Dyne Therapeuticsinc Stock Performance
| DYN Stock | USD 24.98 0.46 1.81% |
On a scale of 0 to 100, Dyne TherapeuticsInc holds a performance score of 6. The firm shows a Beta (market volatility) of 3.14, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Dyne TherapeuticsInc will likely underperform. Please check Dyne TherapeuticsInc's semi variance, and the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Dyne TherapeuticsInc's price patterns will revert.
Risk-Adjusted Performance
6 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Dyne TherapeuticsInc are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting basic indicators, Dyne TherapeuticsInc displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (1.18) | Five Day Return 6.84 | Year To Date Return 92.5 | Ten Year Return 5.19 | All Time Return 5.19 |
1 | Disposition of 162707 shares by Atlas Venture Fund Xi, L.p. of Dyne TherapeuticsInc at 23.14 subject to Rule 16b-3 | 02/16/2024 |
2 | Disposition of 35164 shares by Atlas Venture Fund Xi, L.p. of Dyne TherapeuticsInc at 23.14 subject to Rule 16b-3 | 02/21/2024 |
3 | Disposition of 40455 shares by Atlas Venture Fund Xi, L.p. of Dyne TherapeuticsInc at 24.38 subject to Rule 16b-3 | 02/27/2024 |
4 | Disposition of 2430 shares by Atlas Venture Fund Xi, L.p. of Dyne TherapeuticsInc at 25.25 subject to Rule 16b-3 | 02/28/2024 |
5 | Dyne Therapeutics files mixed securities shelf | 03/05/2024 |
6 | Disposition of 2081 shares by Oxana Beskrovnaya of Dyne TherapeuticsInc at 25.7 subject to Rule 16b-3 | 03/11/2024 |
7 | Disposition of 1030 shares by Farwell Wildon of Dyne TherapeuticsInc at 25.58 subject to Rule 16b-3 | 03/12/2024 |
8 | Dyne Therapeutics to Present at Stifel 2024 Virtual CNS Days | 03/13/2024 |
9 | Chief Operating Officer Of Dyne Therapeutics Sold 71 percent Of Their Shares | 03/15/2024 |
10 | Should You Add Dyne Therapeutics Inc Stock to Your Portfolio Wednesday - InvestorsObserver | 03/20/2024 |
11 | Disposition of tradable shares by Cox John of Dyne TherapeuticsInc subject to Rule 16b-3 | 03/25/2024 |
12 | Dyne Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635 to Newly Appointed President and Chief Executive Officer | 03/27/2024 |
13 | Is Dyne Therapeutics Inc a Leader in the Biotechnology Industry - InvestorsObserver | 03/28/2024 |
14 | Dyne Therapeutics, Inc. Shares Sold by Assenagon Asset Management S.A. - Defense World | 04/02/2024 |
15 | Dyne Therapeutics, Inc. Sees Large Increase in Short Interest - Defense World | 04/16/2024 |
| Begin Period Cash Flow | 172.1 M | |
| Free Cash Flow | -188.9 M |
Dyne |
Dyne TherapeuticsInc Relative Risk vs. Return Landscape
If you would invest 2,116 in Dyne TherapeuticsInc on January 26, 2024 and sell it today you would earn a total of 382.00 from holding Dyne TherapeuticsInc or generate 18.05% return on investment over 90 days. Dyne TherapeuticsInc is generating 0.3427% of daily returns assuming volatility of 3.8909% on return distribution over 90 days investment horizon. In other words, 34% of stocks are less volatile than Dyne, and above 94% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Dyne TherapeuticsInc Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Dyne TherapeuticsInc's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Dyne TherapeuticsInc, and traders can use it to determine the average amount a Dyne TherapeuticsInc's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0881
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | DYN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.89 actual daily | 34 66% of assets are more volatile |
Expected Return
| 0.34 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 6 94% of assets perform better |
Based on monthly moving average Dyne TherapeuticsInc is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Dyne TherapeuticsInc by adding it to a well-diversified portfolio.
Dyne TherapeuticsInc Fundamentals Growth
Dyne Stock prices reflect investors' perceptions of the future prospects and financial health of Dyne TherapeuticsInc, and Dyne TherapeuticsInc fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Dyne Stock performance.
| Return On Equity | -1.37 | ||||
| Return On Asset | -0.64 | ||||
| Current Valuation | 1.94 B | ||||
| Shares Outstanding | 86.18 M | ||||
| Price To Earning | 35.58 X | ||||
| Price To Book | 24.40 X | ||||
| EBITDA | (239.7 M) | ||||
| Net Income | (235.94 M) | ||||
| Cash And Equivalents | 291.84 M | ||||
| Cash Per Share | 5.64 X | ||||
| Total Debt | 27.41 M | ||||
| Debt To Equity | 0.11 % | ||||
| Current Ratio | 11.63 X | ||||
| Book Value Per Share | 1.49 X | ||||
| Cash Flow From Operations | (188.16 M) | ||||
| Earnings Per Share | (3.95) X | ||||
| Market Capitalization | 2.19 B | ||||
| Total Asset | 165.08 M | ||||
| Retained Earnings | (632.51 M) | ||||
| Working Capital | 78.28 M | ||||
| Current Asset | 1.93 B | ||||
| Current Liabilities | 809 M | ||||
About Dyne TherapeuticsInc Performance
To evaluate Dyne TherapeuticsInc Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Dyne TherapeuticsInc generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Dyne Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Dyne TherapeuticsInc market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Dyne's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 49.86 | 48.73 | |
| Return On Tangible Assets | (1.43) | (1.36) | |
| Return On Capital Employed | (2.12) | (2.02) | |
| Return On Assets | (1.43) | (1.36) | |
| Return On Equity | (2.58) | (2.46) |
Things to note about Dyne TherapeuticsInc performance evaluation
Checking the ongoing alerts about Dyne TherapeuticsInc for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Dyne TherapeuticsInc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Dyne TherapeuticsInc had very high historical volatility over the last 90 days | |
| Reported Net Loss for the year was (235.94 M) with profit before taxes, overhead, and interest of 0. | |
| Dyne TherapeuticsInc has about 291.84 M in cash with (188.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.64. | |
| Over 87.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Dyne Therapeutics, Inc. Sees Large Increase in Short Interest - Defense World |
- Analyzing Dyne TherapeuticsInc's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Dyne TherapeuticsInc's stock is overvalued or undervalued compared to its peers.
- Examining Dyne TherapeuticsInc's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Dyne TherapeuticsInc's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Dyne TherapeuticsInc's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Dyne TherapeuticsInc's stock. These opinions can provide insight into Dyne TherapeuticsInc's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dyne TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne TherapeuticsInc guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for Dyne Stock analysis
When running Dyne TherapeuticsInc's price analysis, check to measure Dyne TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dyne TherapeuticsInc is operating at the current time. Most of Dyne TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Dyne TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dyne TherapeuticsInc's price. Additionally, you may evaluate how the addition of Dyne TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |
Is Dyne TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dyne TherapeuticsInc. If investors know Dyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dyne TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.95) | Return On Assets (0.64) | Return On Equity (1.37) |
The market value of Dyne TherapeuticsInc is measured differently than its book value, which is the value of Dyne that is recorded on the company's balance sheet. Investors also form their own opinion of Dyne TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Dyne TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dyne TherapeuticsInc's market value can be influenced by many factors that don't directly affect Dyne TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dyne TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dyne TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dyne TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.